Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arizona for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arizona only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arizona (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Cameron Javid (NPI 1518960632)

Field	Value
Entity Type	Individual
Organization	Cameron Javid
Address	6561 E Carondelet Dr
City	Tucson
State	AZ
ZIP	85710
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 23, 2005

Payer Source	Total Paid
Medicare	$3.4M
Medicaid	$0

Key Findings

Provider is effectively single‑payer: Total Medicare revenue reported is $3.4M while Total Medicaid revenue is none (no Medicaid billing on file), indicating this clinician’s entire recorded public-payer footprint is Medicare. The NPI was enumerated 2005-05-23 (~21 years ago), showing long tenure in the Medicare program that could support established referral relationships and steady Medicare billing patterns.

Revenue is highly concentrated in intravitreal medications: the precomputed top 3 Medicare codes by revenue account for 72.8% of this provider's total Medicare revenue, led by J0178 ($1.4M, 40.2%) with sizable contributions from J2777 ($725.6K, 21.2%) and J2778 ($390.9K, 11.4%). This concentration indicates the practice’s Medicare revenue is driven predominantly by anti‑VEGF and related retina drug administration.

Clinical/service mix aligns with a high-volume retina injection practice: dominant codes are drug injections (J0178, J2777, J2778) supplemented by high-volume retinal imaging and diagnostics such as 92134 (3.6K claims, $103.8K revenue, 3.0%) and office E/M 99214 (2.2K claims, $204.6K revenue, 6.0%). The combination of frequent intravitreal drug billing plus extensive imaging and E/M visits is consistent with a retina specialist managing chronic retinal disease (eg, AMD, diabetic macular edema) with recurrent injections and monitoring.

For major drug codes the provider is a typical national participant rather than a national leader: J0178 ranks #540 of 3204 (83th percentile; typical, unremarkable volume for this code) and J2777 ranks #385 of 2039 (81th percentile; typical, unremarkable volume for this code), indicating volume for the highest‑revenue drugs is within expected peer ranges. These ranks suggest competitive presence in the anti‑VEGF/faricimab market but not market dominance at the national level for medication administration.

The provider is an outlier on diagnostic imaging and level‑4 office visits: 92134 ranks #209 of 26868 (99th percentile; extreme outlier, far above typical national volume) and 99214 ranks #847 of 479517 (100th percentile; extreme outlier, far above typical national volume). Those percentiles indicate substantially heavier use of retinal OCT imaging and higher‑level established patient E/M visits than nearly all national peers, which may reflect practice style or a high follow‑up burden of chronic retinal disease.

Operative retina procedures are a meaningful but smaller part of revenue and activity: 67028 (intravitreal injection as an isolated procedure) shows 2.3K claims, $214.7K revenue (6.3%) and ranks #262 of 4255 (94th percentile; notably above typical national volume), while pars plana vitrectomy codes 67036 ($14.3K) and 67041 ($15K) appear at modest volumes. This pattern indicates the practice performs some OR‑level retinal interventions in addition to ambulatory injections, with injection procedure coding notably above typical peers.

Ancillary drug and compound billing contributes to revenue diversity: J3490 (unclassified drugs) produced $105.2K (3.1%) and J7999 (compounded drug) produced $39.2K (1.1%), alongside J7312 (dexamethasone implant) at $42.3K (1.2%). Presence of unclassified and compounded drug billing plus an intravitreal implant suggests use of non‑standard or specialty pharmaceuticals and implants in a minority but non‑trivial share of cases.

Implications for payers and network partners: because the provider’s public‑payer activity is concentrated in Medicare (no Medicaid billing on file) and revenue is heavily driven by repeat, high‑frequency drug administration and imaging (top 3 codes = 72.8% of Medicare revenue), contracting or utilization management efforts should focus on injection protocols, imaging utilization, and drug procurement/coverage for anti‑VEGF agents rather than Medicaid network expansion. The combination of long NPI tenure (~21 years) and extreme outlier imaging/E/M use suggests predictable, high follow‑up volume that payers should account for in network capacity and cost forecasts.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,990	$690	$1.4M
J2777	Injection, faricimab‑svoa, 0.1 mg	25,020	$30	$725.6K
J2778	Injection, ranibizumab, 0.1 mg	2,150	$180	$390.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,280	$90	$214.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	2,250	$90	$204.6K
J3490	Unclassified drugs	70	$1,620	$105.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,580	$30	$103.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	890	$90	$76.4K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	270	$160	$42.3K
J7999	Compounded drug, not otherwise classified	530	$70	$39.2K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arizona Distribution

Cameron Javid — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arizona

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	8	50	780	$690	$734.8K
J2777	15	50	9,000	$30	$525.8K
Q5128	16	20	520	$220	$207.5K
J2778	6	30	550	$180	$198K
67028	10	60	1,240	$90	$119K
67041	16	20	30	$1,220	$51K
J7312	12	20	270	$160	$48.9K
J7999	22	50	490	$70	$46.8K
67036	16	30	30	$1,030	$37.9K
J9035	9	20	210	$50	$22.5K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Cameron Javid, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rasw, PC	AZ	Retina Specialist (Ophthalmology) Physician	$0	$11.6M
Mark Walsh	AZ	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Sean Garrity	AZ	Ophthalmology Physician	$3.4M	$0
April Harris	AZ	Retina Specialist (Ophthalmology) Physician	$3.4M	$0
Ryan Wong	AZ	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
Andreas Gonzalez	AZ	Ophthalmology Physician	$2.4M	$0
Anthony Joseph	AZ	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
William Stevenson	NV	Retina Specialist (Ophthalmology) Physician	$964K	$0

Nearby Providers

Other providers in the same ZIP code as Cameron Javid, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Easter Seals Blake Foundation	AZ	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$80.8M
Cobros Iii, LLC	AZ	Community/Behavioral Health Agency	$0	$61.4M
Easter Seals Blake Foundation	AZ	Community/Behavioral Health Agency	$0	$24.3M
Saguaro Senior Living, Inc.	AZ	Assisted Living Facility	$0	$22.5M
Arizona Total Care LLC	AZ	Multi-Specialty Clinic/Center	$0	$16.7M
Community Medical Services Arizona-private, LLC	AZ	Methadone Clinic	$164.3K	$14.2M
Solace Behavioral Health LLC	AZ	Community/Behavioral Health Agency	$0	$11.9M
Devereux Foundation	AZ	Mental Illness Community Based Residential Treatment Facility	$0	$8.7M
Caring Connections For Special Needs, LLC	AZ	Community/Behavioral Health Agency	$0	$7.5M
Rapidray LLC	AZ	Portable X-ray and/or Other Portable Diagnostic Imaging Supplier	$406.4K	$732.1K

Cameron Javid — Billing Profile & Reimbursement Data

Sign up for Cameron Javid — Billing Profile & Reimbursement Data policy alerts

Cameron Javid — Billing Profile & Reimbursement Data

Sign up for Cameron Javid — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References